Back to Search
NEAL KLEIMAN, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1922038298IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G2549(TX)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
G2549(TX)
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 1981
Research & Publications (20)
Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug development.
PMID 18569859·Platelets·2008
6-review
Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide?
PMID 16265559·Nat Clin Pract Cardiovasc Med·2005
2-rct
Evolving revascularization approaches for myocardial ischemia.
PMID 14615021·Am J Cardiol·2003
6-review
Antiplatelet therapy and coronary interventions: childhood friends or permanent partners?
PMID 12063805·J Interv Cardiol·2002
8-other
Antiplatelet therapy and coronary interventions: childhood friends or permanent partners?
PMID 12053683·J Interv Cardiol·2002
8-other
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.
PMID 12354426·J Am Coll Cardiol·2002
3-trial
Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide.
PMID 11923794·Am Heart J·2002
3-trial
Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions.
PMID 11156730·J Invasive Cardiol·2000
8-other
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.
PMID 10590183·J Thromb Thrombolysis·2000
3-trial
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators.
PMID 10683348·Circulation·2000
3-trial
Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology.
PMID 10898457·J Am Coll Cardiol·2000
6-review
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
PMID 10966553·Am Heart J·2000
3-trial
Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitro.
PMID 10590186·J Thromb Thrombolysis·2000
8-other
Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent.
PMID 19466381·J Thromb Thrombolysis·2010
7-preclinical
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
PMID 19339264·Eur Heart J·2009
4-observational
Percutaneous paravalvular repair: guidance using live 3-dimensional transesophageal echocardiography.
PMID 19371832·J Am Coll Cardiol·2009
5-case
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
PMID 19463396·JACC Cardiovasc Interv·2009
4-observational
Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
PMID 19576352·Am J Cardiol·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6550 FANNIN ST, SMITH TOWER, SUITE 1901
HOUSTON, TX 77030 - Phone
- (713) 441-1100
Quick Facts
- NPI
- 1922038298
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile